Follicular lymphoma: 2023 update on diagnosis and management
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26737
Abstract: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by diffuse lymphadenopathy, bone marrow involvement, and splenomegaly. Extranodal involvement is less common. Cytopenias are… read more here.
Keywords: lymphoma; diagnosis management; update diagnosis; follicular lymphoma ... See more keywords
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26760
Abstract: Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). read more here.
Keywords: cell; 2023 update; lymphomas 2023; update diagnosis ... See more keywords
Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management
Sign Up to like & getrecommendations! Published in 2023 at "American Journal of Hematology"
DOI: 10.1002/ajh.26796
Abstract: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and rarely hyperviscosity. read more here.
Keywords: waldenstr macroglobulinemia; macroglobulinemia 2023; update diagnosis; waldenstr ... See more keywords
Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
Sign Up to like & getrecommendations! Published in 2023 at "American Journal of Hematology"
DOI: 10.1002/ajh.26822
Abstract: Acute myeloid leukemia (AML) is a frequently fatal bone marrow stem cell cancer characterized by unbridled proliferation of malignant marrow stem cells with associated infection, anemia, and bleeding. An improved understanding of pathophysiology, improvements in… read more here.
Keywords: acute myeloid; myeloid leukemia; leukemia 2023; 2023 update ... See more keywords
Investigational anti IL-13 asthma treatments: a 2023 update.
Sign Up to like & getrecommendations! Published in 2023 at "Expert opinion on investigational drugs"
DOI: 10.1080/13543784.2023.2215425
Abstract: INTRODUCTION IL-13 is a pleiotropic type 2 cytokine important in the pathogenesis of asthma and other eosinophilic disorders. AREAS COVERED Different attempts to directly neutralise IL-13 or block its receptors and the possible impact that… read more here.
Keywords: 2023 update; asthma treatments; asthma; anti asthma ... See more keywords
A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2195539
Abstract: ABSTRACT Introduction Neuropsychiatric symptoms (NPS) in Alzheimer’s Disease (AD) are associated with negative outcomes for patients and their care partners. Agitation is a common and distressing NPS, without safe and effective treatments. Nonpharmacological interventions are… read more here.
Keywords: alzheimer disease; agitation; treatment; update advancements ... See more keywords
The ProteomeXchange consortium at 10 years: 2023 update
Sign Up to like & getrecommendations! Published in 2022 at "Nucleic Acids Research"
DOI: 10.1093/nar/gkac1040
Abstract: Abstract Mass spectrometry (MS) is by far the most used experimental approach in high-throughput proteomics. The ProteomeXchange (PX) consortium of proteomics resources (http://www.proteomexchange.org) was originally set up to standardize data submission and dissemination of public… read more here.
Keywords: years 2023; consortium years; proteomexchange consortium; consortium ... See more keywords
PubChem 2023 update.
Sign Up to like & getrecommendations! Published in 2022 at "Nucleic acids research"
DOI: 10.1093/nar/gkac956
Abstract: PubChem (https://pubchem.ncbi.nlm.nih.gov) is a popular chemical information resource that serves a wide range of use cases. In the past two years, a number of changes were made to PubChem. Data from more than 120 data… read more here.
Keywords: cell line; pubchem; chemical; update ... See more keywords
Lichen sclerosus: The 2023 update
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1106318
Abstract: Lichen sclerosus (LS) is an underdiagnosed inflammatory mucocutaneous condition affecting the anogenital areas. Postmenopausal women are predominantly affected and, to a lesser extent, men, prepubertal children, and adolescents. The etiology of LS is still unknown.… read more here.
Keywords: lichen; sclerosus 2023; lichen sclerosus; treatment ... See more keywords
Morphea: The 2023 update
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1108623
Abstract: Morphea, also known as localized scleroderma, is a chronic inflammatory connective tissue disorder with variable clinical presentations, that affects both adults and children. It is characterized by inflammation and fibrosis of the skin and underlying… read more here.
Keywords: disease; morphea 2023; etiology; morphea ... See more keywords
A 2023 Update on Managing Insomnia in Primary Care: Insights From an Expert Consensus Group.
Sign Up to like & getrecommendations! Published in 2023 at "The primary care companion for CNS disorders"
DOI: 10.4088/pcc.22nr03385
Abstract: Objective: To evaluate the status of management of insomnia disorder, describe gaps in current recognition and treatment, identify current guidance for optimal management, and develop up-to-date educational recommendations for primary care providers. Participants: Four insomnia… read more here.
Keywords: consensus; insomnia; group; primary care ... See more keywords